Advances in our knowledge of pediatric genitourinary tumors are being made
at both the basic science and clinical levels. The molecular mechanisms und
erlying these pediatric malignancies are being uncovered and will aid in un
covering novel treatments. Because of the high success rate in treating the
se tumors, treatment options are being modified to decrease both short- and
long-term morbidity, while maintaining the improved survival. Curr Opin On
col 2000, 12:273-281 (C) 2000 Lippincott Williams & Wilkins, Inc.